Asia Pacific Acne Medication Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Acne Medication Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Acne Medication Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Acne Medication Market Regional Analysis

6.2 Asia Pacific Acne Medication Market Revenue 2020-2030 (US$ Million)

6.3 Asia Pacific Acne Medication Market Forecast Analysis

7. Asia Pacific Acne Medication Market Analysis – by Therapeutic Class

7.1 Retinoids

7.1.1 Overview
7.1.2 Retinoids: Asia Pacific Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Benzoyl Peroxide

7.2.1 Overview
7.2.2 Benzoyl Peroxide: Asia Pacific Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.3 Antibiotics

7.3.1 Overview
7.3.2 Antibiotics: Asia Pacific Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.4 Salicylic Acid

7.4.1 Overview
7.4.2 Salicylic Acid: Asia Pacific Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific Acne Medication Market Analysis – by Formulation

8.1 Topical Medication and Oral Medication

8.1.1 Overview
8.1.2 Topical Medication and Oral Medication: Asia Pacific Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific Acne Medication Market Analysis – by Acne Type

9.1 Non-Inflammatory Acne and Inflammatory Acne

9.1.1 Overview
9.1.2 Non-Inflammatory Acne and Inflammatory Acne: Asia Pacific Acne Medication Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific Acne Medication Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Acne Medication Market Breakdown, by Key Country, 2023 and 2030 (%)
10.2.1.1 Asia Pacific Acne Medication Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.1.1 China: Asia Pacific Acne Medication Market Breakdown, by Therapeutic Class
10.2.1.1.2 China: Asia Pacific Acne Medication Market Breakdown, by Formulation
10.2.1.1.3 China: Asia Pacific Acne Medication Market Breakdown, by Acne Type

10.2.1.2 India: Asia Pacific Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.2.1 India: Asia Pacific Acne Medication Market Breakdown, by Therapeutic Class
10.2.1.2.2 India: Asia Pacific Acne Medication Market Breakdown, by Formulation
10.2.1.2.3 India: Asia Pacific Acne Medication Market Breakdown, by Acne Type

10.2.1.3 Japan: Asia Pacific Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Acne Medication Market Breakdown, by Therapeutic Class
10.2.1.3.2 Japan: Asia Pacific Acne Medication Market Breakdown, by Formulation
10.2.1.3.3 Japan: Asia Pacific Acne Medication Market Breakdown, by Acne Type

10.2.1.4 Australia: Asia Pacific Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Acne Medication Market Breakdown, by Therapeutic Class
10.2.1.4.2 Australia: Asia Pacific Acne Medication Market Breakdown, by Formulation
10.2.1.4.3 Australia: Asia Pacific Acne Medication Market Breakdown, by Acne Type

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Acne Medication Market Breakdown, by Therapeutic Class
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Acne Medication Market Breakdown, by Formulation
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Acne Medication Market Breakdown, by Acne Type

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Teva Pharmaceutical Industries Ltd

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Mayne Pharma Group Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Almirall SA

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Johnson & Johnson

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Sun Pharmaceutical Industries Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Bausch Health Companies Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Galderma SA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Pfizer Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 GSK Plc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Viatris Inc

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Acne Medication Market